𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Progress in the treatment of Hodgkin's disease in the United States, 1973 versus 1983. The patterns of care study

✍ Scribed by Richard T. Hoppe; Alexandra L. Hanlon; Gerald E. Hanks; Jean B. Owen

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
420 KB
Volume
74
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Changes in patterns of prostate cancer c
Changes in patterns of prostate cancer care in the United States: Results of American College of Surgeons Commission on Cancer Studies, 1974–1993
✍ Mettlin, Curtis πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 54 KB πŸ‘ 2 views

## Background: Advances in medical and public health practice have led to many changes in patterns of prostate cancer care. data from several studies of prostate cancer by the commission on cancer of the american college of surgeons provide information on the directions, magnitudes, and consequence

The clinical usefulness of serum copper
The clinical usefulness of serum copper determinations in Hodgkin's disease. A retrospective study of 241 patients from 1963–1973
✍ E. B. Thorling; K; Thorling πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 483 KB πŸ‘ 1 views

Serum copper determinations were routinely performed in 141 men and 100 women with histologically verified Hodgkin's disease, admitted to the Radium Centre for Jutland over a 10-year-period from January 1, 1963, to January 1, 1973. The previously described variations in serum copper with the activit

Sickle cell disease in the United States
Sickle cell disease in the United States: Looking back and forward at 100 years of progress in management and survival
✍ Hari Prabhakar; Carlton Haywood Jr.; Robert Molokie πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 2 views

## Abstract The past 100 years since James Herrick's first description of sickle cell disease in the United States have been characterized by the gradual development of management strategies. We review the progress in sickle cell disease management in the United States over the past 100 years, with

Comparative study of selegiline plus L-d
Comparative study of selegiline plus L-dopa–carbidopa versus L-dopa–carbidopa alone in the treatment of parkinson's disease
✍ Timothy Brannan; Dr. Melvin D. Yahr πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 383 KB πŸ‘ 1 views

The long-term effect of selegiline (L-deprenyl) in the treatment of Parkinson's disease has not been clearly delineated. We report on a group of patients whose treatment was initiated with selegiline (n = 43) and then subsequently included L-dopa-carbidopa (Sinemet) and in whom an extended period o